Megan Greally

575 total citations
41 papers, 399 citations indexed

About

Megan Greally is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Megan Greally has authored 41 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 17 papers in Surgery. Recurrent topics in Megan Greally's work include Gastric Cancer Management and Outcomes (16 papers), Esophageal Cancer Research and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Megan Greally is often cited by papers focused on Gastric Cancer Management and Outcomes (16 papers), Esophageal Cancer Research and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Megan Greally collaborates with scholars based in Ireland, United States and United Kingdom. Megan Greally's co-authors include Andrea Cercek, Ciara M. Kelly, David H. Ilson, Rajiv Agarwal, Geoffrey Y. Ku, Thomas D. Cooney, Yelena Y. Janjigian, Rosa Coll, Niamh Coleman and Joanne F. Chou and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Megan Greally

37 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megan Greally Ireland 9 231 161 121 68 49 41 399
Ji Hyun Park South Korea 8 123 0.5× 146 0.9× 60 0.5× 94 1.4× 36 0.7× 22 307
Beate Haugk United Kingdom 15 326 1.4× 139 0.9× 211 1.7× 48 0.7× 82 1.7× 40 590
Rambha Pandey India 10 181 0.8× 160 1.0× 71 0.6× 54 0.8× 105 2.1× 50 397
See‐Chun Phan United States 11 303 1.3× 249 1.5× 66 0.5× 45 0.7× 65 1.3× 17 435
Marta Caporale Italy 11 253 1.1× 150 0.9× 119 1.0× 96 1.4× 82 1.7× 16 427
Katia Dotti Italy 12 364 1.6× 149 0.9× 99 0.8× 114 1.7× 56 1.1× 28 514
Geoff Chong Australia 9 274 1.2× 117 0.7× 105 0.9× 111 1.6× 22 0.4× 25 414
Jamie Weaver United Kingdom 12 109 0.5× 107 0.7× 98 0.8× 35 0.5× 105 2.1× 35 361
W Schmiegel Germany 11 118 0.5× 63 0.4× 72 0.6× 54 0.8× 47 1.0× 25 294

Countries citing papers authored by Megan Greally

Since Specialization
Citations

This map shows the geographic impact of Megan Greally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Greally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Greally more than expected).

Fields of papers citing papers by Megan Greally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Greally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Greally. The network helps show where Megan Greally may publish in the future.

Co-authorship network of co-authors of Megan Greally

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Greally. A scholar is included among the top collaborators of Megan Greally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Greally. Megan Greally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Gargi, Bryan T. Hennessy, Oscar S. Breathnach, et al.. (2025). Cutaneous Immune‐Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors for Patients With Advanced Solid Organ Malignancies. International Journal of Dermatology. 65(4). 790–796.
2.
Keane, Fergus, Denis Evoy, James Geraghty, et al.. (2024). Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland. Current Oncology. 31(3). 1302–1310. 1 indexed citations
3.
4.
Moy, Ryan H., Megan Greally, Joanne F. Chou, et al.. (2022). Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma. Cancer Chemotherapy and Pharmacology. 89(2). 255–265. 1 indexed citations
5.
Jayaprakasam, Vetri Sudar, Peter Gibbs, Natalie Gangai, et al.. (2022). Can 18F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?. Cancers. 14(12). 3035–3035. 8 indexed citations
6.
Greally, Megan, Joanne F. Chou, Walid K. Chatila, et al.. (2019). Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer. Clinical Cancer Research. 25(20). 6160–6169. 75 indexed citations
7.
Greally, Megan, Rajiv Agarwal, Imane El Dika, et al.. (2019). Maximizing response: a case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma. Journal of Gastrointestinal Oncology. 10(2). 367–372. 5 indexed citations
8.
Bonanni, Laura, Megan Greally, Donal Maguire, et al.. (2019). neoadjuvant therapy for borderline resectable pancreatic ductal adenocarcinoma (PDA) involving a high volume pancreatic centre in Ireland. HPB. 21. S976–S976. 1 indexed citations
9.
Greally, Megan, Henry Walch, Joanne F. Chou, et al.. (2019). Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy.. Journal of Clinical Oncology. 37(15_suppl). 4047–4047. 1 indexed citations
10.
Toomey, Sinéad, Megan Greally, Fergus Keane, et al.. (2019). Genomic profiling of a dedifferentiated mucosal melanoma following exposure to immunotherapy. Melanoma Research. 30(2). 213–218. 3 indexed citations
11.
Greally, Megan, Niamh Coleman, Cecily Quinn, et al.. (2018). Where youth matters—clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer. Irish Journal of Medical Science (1971 -). 188(1). 59–67. 4 indexed citations
12.
Greally, Megan, Ciara M. Kelly, & Andrea Cercek. (2018). HER2: An emerging target in colorectal cancer. Current Problems in Cancer. 42(6). 560–571. 72 indexed citations
13.
Greally, Megan, Joanne F. Chou, Daniela Molena, et al.. (2018). Positron-Emission Tomography Scan–Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography Nonresponders. Journal of Thoracic Oncology. 14(3). 540–546. 12 indexed citations
14.
Greally, Megan, et al.. (2018). Indolent Nodal Relapse of Colon Carcinoma with Associated Tumor Thrombus Invading the Superior Mesenteric Vein. Journal of Gastrointestinal Cancer. 50(3). 660–664. 1 indexed citations
15.
Keane, Fergus, et al.. (2018). Prostate-specific membrane antigen (PSMA) PET-CT imaging in the investigation and management of biochemical recurrence in prostate cancer.. Journal of Clinical Oncology. 36(6_suppl). 208–208. 3 indexed citations
16.
Rho, Young Soo, Marine Gilabert, Karol Połom, et al.. (2017). Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study. Clinical Colorectal Cancer. 16(4). 334–342. 54 indexed citations
17.
Picardo, Sarah, Jing Sui, Megan Greally, et al.. (2017). Oncotype DX score, menopausal status and body mass index. Annals of Oncology. 28. v59–v59. 4 indexed citations
18.
19.
Greally, Megan, et al.. (2016). A Rare Case of Metastatic Primary Peritoneal Adenocarcinoma Presenting as Breast Cancer. 2(3). 1 indexed citations
20.
Greally, Megan & D. F. Roberts. (1991). A study of digital dermatoglyphics in Ireland. Annals of Human Biology. 18(6). 485–496. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji Hyun Park Breakdown of academic impact, for papers by Beate Haugk Breakdown of academic impact, for papers by Rambha Pandey Breakdown of academic impact, for papers by See‐Chun Phan Breakdown of academic impact, for papers by Marta Caporale Breakdown of academic impact, for papers by Katia Dotti Breakdown of academic impact, for papers by Geoff Chong Breakdown of academic impact, for papers by Jamie Weaver Breakdown of academic impact, for papers by W Schmiegel
Rankless by CCL
2026